House Floor·Last action 153 days ago

HR2319 Boosts Lung Cancer Research for Women

Officially: Women and Lung Cancer Research and Preventive Services Act of 2025

HR2319 directs a review of lung cancer research focused on women and underserved groups. Affects women by improving screening and awareness.

Where it stands

House Floor · Floor consideration Sat, Apr 25

Today. Members are taking positions right now.

What this bill actually does

Interagency review: Conducts a review of lung cancer research focused on women and underserved groups.
Report to Congress: Requires a report with findings and recommendations within two years.

↓ Why your message matters here

The chamber votes today — constituent contact in the final stretch is the single biggest factor in how undecided members break.

The debate

What people are saying about this bill

✓Arguments in support

Addresses disparities: The bill focuses on closing research gaps for women and underserved groups, who often face different risk factors and outcomes in lung cancer.
Improves access: By recommending expanded screening strategies, the bill aims to reduce late-stage diagnoses in underserved populations.
Enhances awareness: Public campaigns mandated by the bill could increase early detection rates, particularly in communities with low awareness.

✕Arguments against

Potential duplication: Critics might argue that the review overlaps with existing efforts by agencies like the NIH and CDC, potentially wasting resources.
Lacks direct action: The bill only produces recommendations, not immediate changes, which could delay help for those in need.
Narrow focus: Some might say the bill's focus on women and underserved groups overlooks broader lung cancer issues.

Where this bill is in the process

Legislative timeline

✓

Introduced

Introduced in House

—

✓

House Committee

Under House committee consideration

—

●

House Floor Vote

Voted on by House

Latest: Placed on the Union Calendar, Calendar No. 332. (11/18/2025)

NOV 18

○

Passed House

Approved by House

—

○

Senate Review

Sent to Senate for consideration

—

○

Passed Both Chambers

Approved by both House and Senate

—

○

Signed into Law

Signed by the President

—

For more detail

Menu

HR2319 Boosts Lung Cancer Research for Women

What people are saying about this bill

Legislative timeline

Read deeper